Dow Down 0.11% Nasdaq Up 0.09%

Navidea Biopharmaceuticals, Inc (NAVB)

-NYSE MKT
0.71 Down 0.01(1.81%) Dec 2, 4:00PM EST
|After Hours : 0.68 Down 0.03 (4.23%) Dec 2, 4:41PM EST
Prev Close:0.72
Open:0.71
Bid:0.70 x 1000
Ask:0.81 x 1000
1y Target Est:1.25
Beta:-0.254035
Next Earnings Date:N/A
Day's Range:0.70 - 0.73
52wk Range:0.26 - 1.51
Volume:893,399
Avg Vol (3m):2,210,930
Market Cap:110.40M
P/E (ttm):N/A
EPS (ttm):-0.08
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NAVB

Comparison

Symbol% ChgMkt Cap
NAVBDown 1.81%110.40M
LLYUp 2.64%71.45B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.91
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.08
Quarterly EPS Est (Sep-16) :-0.02
Mean Recommendation*:5.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback